City Therapeutics Announces Pricing of Upsized Initial Public Offering
City Therapeutics priced an upsized IPO of 11,111,111 shares at $18.00 per share, with expected gross proceeds of approximately $200.0 million. Underwriters hold a 30-day option on up to 1,666,666 additional shares. Goldman Sachs, Jefferies, Stifel, and Oppenheimer are joint book-running managers; the stock begins trading on Nasdaq under CTY on October 16, with closing expected October 19.
Key figures
- Deal Value Usd
- 200000000
- Offering Price
- 18
- Shares Offered
- 11111111
- Underwriter option days
- 30
- Underwriter option shares
- 1666666
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.